
|Videos|June 3, 2021
GPEx Boost- The Next Generation of Cell Line Development
Author(s)Catalent
Trending on Pharmaceutical Technology
1
GSK Acquires Nuvalent for $10.6 Billion in Lung Cancer Push
2
USP Reports Drug Discontinuations on the Rise
3
Why Big Pharma Is Betting Billions on Protein Degraders for Cancer
4
Patient Access to Radiopharmaceuticals
5




